Bulk Planar Junctionless Transistor (BPJLT): An Attractive Device Alternative for Scaling von Gundapaneni, S, Ganguly, S, Kottantharayil, A

Volltext

Enhanced Electrostatic Integrity of Short-Channel Junctionless Transistor With High- \kappa Spacers von Gundapaneni, S., Ganguly, S., Kottantharayil, A.

Volltext

Effect of Band-to-Band Tunneling on Junctionless Transistors von Gundapaneni, S., Bajaj, M., Pandey, R. K., Murali, K. V. R. M., Ganguly, S., Kottantharayil, A.

Volltext

Macro Finite Element for Analysis of Textile Composites von Whitcomb, John, Woo, Kyeongsik, Gundapaneni, Sitaram

Volltext

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy von Maurer, Mathew S, Schwartz, Jeffrey H, Gundapaneni, Balarama, Elliott, Perry M, Merlini, Giampaolo, Waddington-Cruz, Marcia, Kristen, Arnt V, Grogan, Martha, Witteles, Ronald, Damy, Thibaud, Drachman, Brian M, Shah, Sanjiv J, Hanna, Mazen, Judge, Daniel P, Barsdorf, Alexandra I, Huber, Peter, Patterson, Terrell A, Riley, Steven, Schumacher, Jennifer, Stewart, Michelle, Sultan, Marla B, Rapezzi, Claudio

Volltext

Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy von Amass, Leslie, Li, Huihua, Gundapaneni, Balarama K, Schwartz, Jeffrey H, Keohane, Denis J

Volltext

Visual benefits and complications following neodymium-doped yttrium aluminum garnet (Nd: YAG) capsulotomy von Ajay R Kamath, Gundapaneni, Ramya

Volltext

HCV universal EHR prompt successfully increases screening, highlights potential disparities von Hack, Benjamin, Sanghavi, Kavya, Gundapaneni, Sravya, Fernandez, Stephen, Hughes, Justin, Huang, Sean, Basch, Peter, Fong, Allan, Fishbein, Dawn

Volltext

Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR‐ACT) and long‐term extension study von Damy, Thibaud, Garcia‐Pavia, Pablo, Hanna, Mazen, Judge, Daniel P., Merlini, Giampaolo, Gundapaneni, Balarama, Patterson, Terrell A., Riley, Steven, Schwartz, Jeffrey H., Sultan, Marla B., Witteles, Ronald

Volltext

Tafamidis delays neurological progression comparably across Val30Met and non‐Val30Met genotypes in transthyretin familial amyloid polyneuropathy von Gundapaneni, B. K., Sultan, M. B., Keohane, D. J., Schwartz, J. H.

Volltext

Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer von Padala, Chiranjeevi, Tupurani, Mohini Aiyengar, Puranam, Kaushik, Gantala, Srilatha, Shyamala, Nivas, Kondapalli, Mrudula Spurthi, Gundapaneni, Kishore Kumar, Mudigonda, Saraswati, Galimudi, Rajesh Kumar, Kupsal, Keerthi, Nanchari, Santoshi Rani, Chavan, Uday, Chinta, Sanjeeva Kumari, Mukta, Srinivasulu, Satti, Vishnupriya, Hanumanth, Surekha Rani

Volltext

Reply to ‘Effects of tafamidis on heart failure hospitalization: The tale of the dog that did not bark’ von Elliott, Perry, Gundapaneni, Balarama, Garcia‐Pavia, Pablo

Volltext

A rare differential diagnosis of air under the diaphragm on abdominal X-ray - Chilaiditi's syndrome in a child with skin wrinkle syndrome von Gundapaneni, Sreekar, Bhattacharya, Debashish

Volltext

Response by Elliott et al to Letter Regarding Article, “Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy” von Elliott, Perry, Gundapaneni, Balarama, Sultan, Marla B.

Volltext

Atrial fibrillation as a prognostic factor for all-cause mortality in patients with transthyretin amyloid cardiomyopathy von Witteles, R, Sultan, M B, Gundapaneni, B, Garcia-Pavia, P

Volltext

Free Light-Chain Levels in Patients with Transthyretin Amyloid Cardiomyopathy in Attr-ACT von Hoffman, James E, Sultan, Marla B., Gundapaneni, Balarama, Witteles, Ronald

Volltext

genome-wide RNAi screen for Wnt/β-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer von Tang, Wei, Dodge, Michael, Gundapaneni, Deepika, Michnoff, Carolyn, Roth, Michael, Lum, Lawrence

Volltext

Improved long‐term survival with tafamidis treatment in patients with transthyretin amyloid cardiomyopathy and severe heart failure symptoms von Elliott, Perry, Gundapaneni, Balarama, Sultan, Marla B., Ines, Monica, Garcia‐Pavia, Pablo

Volltext

Treatment With Tafamidis Slows Disease Progression in Early-Stage Transthyretin Cardiomyopathy von Sultan, Marla B, Gundapaneni, Balarama, Schumacher, Jennifer, Schwartz, Jeffrey H

Volltext

Abstract 13149: Survival Benefit With Higher Dose Tafamidis in Patients With Hereditary and Wild-type Transthyretin Amyloid Cardiomyopathy von Shah, Sanjiv J, Gundapaneni, Balarama, Sultan, Marla B, Merlini, Giampaolo

Volltext